Aggressive Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Recruiting
  • CLL
  • +9 more
  • TG-1801
  • Ublituximab
  • Fayetteville, Arkansas
  • +4 more
2022-03-22
Mar 22, 2022
N
Recruiting
  • Lymphoma, Non-Hodgkin
  • +9 more
  • NKX019
  • Denver, Colorado
  • +6 more
2022-01-19
Jan 19, 2022
U
Completed
  • Aggressive Lymphoma
  • Bendamustine and subcutaneous rituximab
  • Göttingen, Germany
    Prof. Trümper
2018-12-27
Dec 27, 2018
G
Completed
  • Aggressive Lymphoma
  • +2 more
  • Rituximab, Gemcitabine, Oxaliplatin, Dexametasone
  • Badalona, Barcelona, Spain
  • +27 more
2017-10-27
Oct 27, 2017